.svg)
Almaden Genomics' g.nome™ Further Enhances Single-Cell Analysis
READ MORE
Almaden Genomics has incorporated an end-to-end solution to process, analyze, and visualize single-cell RNAseq data.
Catalyze Dallas Becomes Catalyze Partners
READ MORE
Catalyze Dallas is now Catalyze Partners, a name that better reflects its global focus and identity as a new alternative asset class investment vehicle.
Almaden Adds Pre-Built Workflows to Speed Single-Cell RNA-seq Analysis
READ MORE
Almaden Genomics has introduced pre-built workflows for single-cell RNA-seq analysis. This game-changing feature empowers researchers to delve deeper into cellular diversity and disease mechanisms.
Injection Molded Reinforced Polymer Plays Key Role in Next Gen Drone
READ MORE
We spoke to Design-2-Part magazine about our flagship HX5® thermoplastic material and its game-changing role in drone design and manufacturing with BlueHalo.
Catalyze Dallas Names Nick Brown Principal
READ MORE
Catalyze has named Nick Brown as Principal, an executive corporate development role identifying intellectual property for spinout.
Almaden Builds Business Operations to Catch up With Technology
READ MORE
Almaden Genomics building business operations to keep up with technological innovation
Almaden Names Ellen Gordon VP, Head of Business Development
READ MORE
Almaden Genomics has named Ellen Gordon as VP, Head of Business Development. She will help Almaden partner with clients to accelerate genomic research.
Almaden Genomics Names Board of Advisors
READ MORE
Almaden has announced its Board of Advisors, a highly regarded group of healthcare leaders with experience across a variety of industries.
OmicsEdge Partners with Almaden to Streamline Drug Discovery
READ MORE
A new drug discovery service from OmicsEdge using Almaden's g.nome™ makes it easy for labs to quickly analyze a patient’s medical condition and genomics.